Fatty acid amide hydrolase (FAAH) and the endocannabinoid system in obesity: Mechanistic insights and pharmacological opportunities beyond incretin‐based therapies

Documenti analoghi

• Impact of incretin analogues on lipid and lipoprotein metabolism in obesity and diabetes
  di: Andrea Baragetti, et al.
  Pubblicazione: (2026)
• Amylin analogues as a novel perspective in anti‐obesity therapy
  di: Thomas A. Lutz
  Pubblicazione: (2026)
• Assessing GPT‐4's accuracy in answering clinical pharmacological questions on pain therapy
  di: Anna Stroop, et al.
  Pubblicazione: (2025)
• P2X7 receptor‐dependent increase in endocannabinoid 2‐arachidonoyl glycerol production by neuronal cells in culture: Dynamics and mechanism
  di: Simar Singh, et al.
  Pubblicazione: (2024)
• Fatty acid binding protein 3 activates endothelial adhesion of circulating monocytes and impairs endothelial angiogenesis
  di: Yen‐Wen Wu, et al.
  Pubblicazione: (2025)